Literature DB >> 22289031

The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo.

Elzbieta Janda1, Maddalena Parafati, Serafina Aprigliano, Cristina Carresi, Valeria Visalli, Iolanda Sacco, Domenica Ventrice, Tiziana Mega, Nuria Vadalá, Stefano Rinaldi, Vincenzo Musolino, Ernesto Palma, Santo Gratteri, Domenicantonio Rotiroti, Vincenzo Mollace.   

Abstract

BACKGROUND AND PURPOSE The mechanisms of paraquat (PQ)-induced toxicity are poorly understood and PQ poisoning is often fatal due to a lack of effective antidotes. In this study we report the effects of N-[2-(2-methoxy-6H-dipyrido{2,3-a:3,2-e}pyrrolizin-11-yl)ethyl]-2-furamide (NMDPEF), a melatonin-related inhibitor of quinone oxidoreductase2 (QR2) on the toxicity of PQ in vitro & in vivo. EXPERIMENTAL APPROACH Prevention of PQ-induced toxicity was tested in different cells, including primary pneumocytes and astroglial U373 cells. Cell death and reactive oxygen species (ROS) were analysed by flow cytometry and fluorescent probes. QR2 silencing was achieved by lentiviral shRNAs. PQ (30 mg·kg(-1)) and NMDPEF were administered i.p. to Wistar rats and animals were monitored for 28 days. PQ toxicity in the substantia nigra (SN) was tested by a localized microinfusion and electrocorticography. QR2 activity was measured by fluorimetry of N-benzyldihydronicotinamide oxidation. KEY RESULTS NMDPEF potently antagonized non-apoptotic PQ-induced cell death, ROS generation and inhibited cellular QR2 activity. In contrast, the cytoprotective effect of melatonin and apocynin was limited and transient compared with NMDPEF. Silencing of QR2 attenuated PQ-induced cell death and reduced the efficacy of NMDPEF. Significantly, NMDPEF (4.5 mg·kg(-1)) potently antagonized PQ-induced systemic toxicity and animal mortality. Microinfusion of NMDPEF into SN prevented severe behavioural and electrocortical effects of PQ which correlated with inhibition of malondialdehyde accumulation in cells and tissues. CONCLUSIONS AND IMPLICATIONS NMDPEF protected against PQ-induced toxicity in vitro and in vivo, suggesting a key role for QR2 in the regulation of oxidative stress.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22289031      PMCID: PMC3570002          DOI: 10.1111/j.1476-5381.2012.01870.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway.

Authors:  Elzbieta Janda; Gabi Litos; Stefan Grünert; Julian Downward; Hartmut Beug
Journal:  Oncogene       Date:  2002-08-01       Impact factor: 9.867

2.  An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.

Authors:  S Harada; C Fujii; A Hayashi; N Ohkoshi
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

3.  Identification of the melatonin-binding site MT3 as the quinone reductase 2.

Authors:  O Nosjean; M Ferro; F Coge; P Beauverger; J M Henlin; F Lefoulon; J L Fauchere; P Delagrange; E Canet; J A Boutin
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 4.  Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2).

Authors:  S Chen; K Wu; R Knox
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

5.  The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic.

Authors:  Vincenzo Mollace; Michelangelo Iannone; Carolina Muscoli; Emesto Palma; Teresa Granato; Vincenzo Rispoli; Robert Nisticò; Domenicantonio Rotiroti; Daniela Salvemini
Journal:  Neurosci Lett       Date:  2003-01-02       Impact factor: 3.046

Review 6.  Parkinson's disease and pesticides: a toxicological perspective.

Authors:  Jaime M Hatcher; Kurt D Pennell; Gary W Miller
Journal:  Trends Pharmacol Sci       Date:  2008-04-29       Impact factor: 14.819

7.  Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.

Authors:  Ke-Da Yu; Gen-Hong Di; Wen-Tao Yuan; Lei Fan; Jiong Wu; Zhen Hu; Zhen-Zhou Shen; Ying Zheng; Wei Huang; Zhi-Ming Shao
Journal:  Hum Mol Genet       Date:  2009-04-07       Impact factor: 6.150

8.  Quinone reductase 2 is a catechol quinone reductase.

Authors:  Yue Fu; Leonid Buryanovskyy; Zhongtao Zhang
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

9.  Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.

Authors:  Delwin J Long; Karim Iskander; Amos Gaikwad; Meral Arin; Dennis R Roop; Richard Knox; Roberto Barrios; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

10.  An effective antidote for paraquat poisonings: the treatment with lysine acetylsalicylate.

Authors:  R J Dinis-Oliveira; H Pontes; M L Bastos; F Remião; J A Duarte; F Carvalho
Journal:  Toxicology       Date:  2008-11-06       Impact factor: 4.221

View more
  11 in total

Review 1.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 2.  Defective autophagy in Parkinson's disease: role of oxidative stress.

Authors:  Elzbieta Janda; Ciro Isidoro; Cristina Carresi; Vincenzo Mollace
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

3.  Paraquat research: do recent advances in limiting its toxicity make its use safer?

Authors:  Teresa Baltazar; Ricardo Jorge Dinis-Oliveira; José Alberto Duarte; Maria de Lourdes Bastos; Félix Carvalho
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

4.  Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection.

Authors:  Elzbieta Janda; Antonella Lascala; Cristina Carresi; Maddalena Parafati; Serafina Aprigliano; Vanessa Russo; Claudia Savoia; Elena Ziviani; Vincenzo Musolino; Federica Morani; Ciro Isidoro; Vincenzo Mollace
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

5.  Contribution of Sigma-1 receptor to cytoprotective effect of afobazole.

Authors:  Mikhail V Voronin; Ilya A Kadnikov
Journal:  Pharmacol Res Perspect       Date:  2016-11-07

6.  A user-friendly herbicide derived from photo-responsive supramolecular vesicles.

Authors:  Cheng Gao; Qiaoxian Huang; Qingping Lan; Yu Feng; Fan Tang; Maggie P M Hoi; Jianxiang Zhang; Simon M Y Lee; Ruibing Wang
Journal:  Nat Commun       Date:  2018-07-27       Impact factor: 14.919

7.  A Synthetic Receptor as a Specific Antidote for Paraquat Poisoning.

Authors:  Xiangjun Zhang; Xiaoqiu Xu; Shengke Li; Lanlan Li; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-01-21       Impact factor: 11.556

8.  Apigenin and Luteolin Regulate Autophagy by Targeting NRH-Quinone Oxidoreductase 2 in Liver Cells.

Authors:  Elzbieta Janda; Concetta Martino; Concetta Riillo; Maddalena Parafati; Antonella Lascala; Vincenzo Mollace; Jean A Boutin
Journal:  Antioxidants (Basel)       Date:  2021-05-13

Review 9.  How Parkinsonian toxins dysregulate the autophagy machinery.

Authors:  Ruben K Dagda; Tania Das Banerjee; Elzbieta Janda
Journal:  Int J Mol Sci       Date:  2013-11-08       Impact factor: 5.923

10.  Qualitative and quantitative analysis of the proautophagic activity of Citrus flavonoids from Bergamot Polyphenol Fraction.

Authors:  Elzbieta Janda; Raffaele Salerno; Concetta Martino; Antonella Lascala; Daniele La Russa; Manuela Oliverio
Journal:  Data Brief       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.